Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Crypto Analyst Who Said in July That His Long-Term Target for XRP Is $8-10 Explains Why He Just Spent 8 Bitcoins to Buy His Latest Watch
-
Markets Wait For The Fed's Forward Guidance
-
Analyst On Why Ethereum Flipping Bitcoin Won't Happen Anytime Soon
-
Daseke Ascends 14% On Decision To Buy Back Founder’s Stake
-
First Republic Down 10% Respite Upbeat Quarterly Results